| Walgreens #16155 | |
| 418 Us Highway 264 Byp, Belhaven, North Carolina 27810 | |
| (252) 943-6260 |
| Name | Walgreens #16155 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 418 Us Highway 264 Byp, Belhaven, North Carolina 27810 |
| Type | Pharmacy |
| Phone | (252) 943-6260 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.
In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, undergraduate researchers from the University of Alberta's Radiation Therapy Program in the Faculty of Medicine and Dentistry describe how LGBTQ2SPIA+ patients face unique cancer risks, including fear of discrimination, higher incidence of certain cancer sites, and lower screening rates, resulting in more cancers detected at later stages.
International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology's 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.
Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 8 days ago
| NPI Number | 1093825796 |
| Organization Name | KERR DRUG INC |
| Doing Business As | KERR DRUG |
| Type | Pharmacy |
| Address | 418 Us Highway 264 Byp, Belhaven, NC 27810 |
| Phone Number | 252-943-6260 |
News Archive
Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.
In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, undergraduate researchers from the University of Alberta's Radiation Therapy Program in the Faculty of Medicine and Dentistry describe how LGBTQ2SPIA+ patients face unique cancer risks, including fear of discrimination, higher incidence of certain cancer sites, and lower screening rates, resulting in more cancers detected at later stages.
International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology's 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.
Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 8 days ago
| NPI Number | 1255767869 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #16155 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 418 Us Highway 264 Byp, Belhaven, NC 27810 |
| Phone Number | 252-943-6260 |
News Archive
Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.
In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, undergraduate researchers from the University of Alberta's Radiation Therapy Program in the Faculty of Medicine and Dentistry describe how LGBTQ2SPIA+ patients face unique cancer risks, including fear of discrimination, higher incidence of certain cancer sites, and lower screening rates, resulting in more cancers detected at later stages.
International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology's 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.
Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 8 days ago
News Archive
Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.
In an upcoming issue of the Journal of Medical Imaging and Radiation Sciences, published by Elsevier, undergraduate researchers from the University of Alberta's Radiation Therapy Program in the Faculty of Medicine and Dentistry describe how LGBTQ2SPIA+ patients face unique cancer risks, including fear of discrimination, higher incidence of certain cancer sites, and lower screening rates, resulting in more cancers detected at later stages.
International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology's 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.
Researchers have designed a urine test that can simultaneously measure the extent of a potential carcinogenic process and a marker of garlic consumption in humans.
AMDL has announced that the US Food and Drug Administration (FDA) has issued a letter of substantial equivalence to an existing predicate device and granted clearance to market the AMDL-ELISA DR-70(R) (FDP) as a safe and effective blood test for monitoring patients who have been previously diagnosed with colorectal cancer (CRC).
› Verified 8 days ago
Oneals Drug Store Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 820 W. Main St, Belhaven, North Carolina 27810 Phone: (252) 943-2643 | |
Pungo River Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 892 Us Hwy 264 E Byp, Belhaven, North Carolina 27810 Phone: (252) 943-2585 | |
Walgreens #16155 Type: Pharmacy Location: 418 Us Highway 264 Byp, Belhaven, North Carolina 27810 Phone: (252) 943-6260 |